Köster B, Ritter J, Bode U
Klin Padiatr. 1984 May-Jun;196(3):178-80. doi: 10.1055/s-2007-1025603.
Life-threatening anaphylactic reactions to VM-26 are rare. In this report two patients with anaphylactic reactions after the first VM-26 applications in the German neuroblastoma therapy protocol GPO-NB-82 are described. After combination of VM-26 with dexamethasone, repetition of these reactions did not occur any more.